Kelly C. Broderick

Statistics

Publications

Citations

116

H-Index

Active since

2015

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Kelly C. Broderick is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in infectious diarrhea, cost-effectiveness analysis, and clinical epidemiology.

Publications per year

2015–2017

Publications

Impact of Clostridium difficile-associated diarrhea on acute care length of stay, hospital costs, and readmission: A multicenter retrospective study of inpatients, 2009-2011

Glenn Magee, Marcie Strauss, Sheila Μ. Thomas et al. · American Journal of Infection Control · 2015 · 71 citations · Full text

Public Health, Infectious Diseases, Clinical Epidemiology +12

Mortality, Hospital Costs, Payments, and Readmissions Associated With Clostridium difficile Infection Among Medicare Beneficiaries

Edward Drozd, Timothy J. Inocencio, Shamonda F. Braithwaite et al. · Infectious Diseases in Clinical Practice · 2015 · 26 citations · Full text

Health Professions, Health Administration, Health Services Administration +17

Fidaxomicin versus Vancomycin as a First‐Line Treatment for <i>Clostridium difficile</i>–Associated Diarrhea in Specific Patient Populations: A Pharmacoeconomic Evaluation

Kelly R. Reveles, Jennifer L. Backo, Frank A. Corvino et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2017 · 19 citations · Full text

Pharmacy, Infectious Diseases, Pharmacoeconomics +15

1–3 of 3